secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2025-11-24T23:59:59+00:00
Accession:  0000914475-25-000186
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine extends former CMO Eiry Roberts as Strategic Advisor through Dec 31, 2026
--------------------------------------------------------------------------------

- Roberts, former CMO, transitioned to Strategic Advisor effective June 2, 2025; term extended to Dec 31, 2026 (Amended Employment Agreement).
- Base salary of $731,400 through Dec 31, 2025; future salary to be set by Compensation Committee thereafter.
- Annual cash incentive bonus target 60% of base pay for 2025 and 2026, subject to corporate and individual goals.
- Employment agreement expires Dec 31, 2026 unless earlier terminated; no severance upon natural expiration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/0000914475-25-000186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447525000186/nbix-20251121.htm
  HTML page:      https://secwatch.observer/filing/0000914475-25-000186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer